Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: PMBHF ) N/A UNCHANGED Last Price Updated: 9:46 AM EST, Jan 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1200 Today's Range N/A - N/A 52wk Range 0.0316 - 0.1374 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More January 15, 2024 Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024. Via Benzinga Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More January 08, 2024 Welcome to Benzinga's weekly psychedelics news roundup. We have pulled together several must-read news items from the last week of December 2023 and the first of January 2024. Via Benzinga Performance More News Read More PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance January 08, 2024 From PharmAla Biotech Via GlobeNewswire Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market November 08, 2023 Via Benzinga PharmAla Begins Trading on OTCQB September 06, 2023 From PharmAla Biotech Via GlobeNewswire Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 Via Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 Via Benzinga PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment July 31, 2023 Via Benzinga PharmAla Files Patent for Novel MDXX Molecule PharmAla-1 July 31, 2023 From PharmAla Biotech Via GlobeNewswire Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials July 24, 2023 Via Benzinga Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More July 11, 2023 Via Benzinga PharmAla's Australian JV Cortexa Orders First Commercial MDMA & Psilocybin Shipment July 05, 2023 Via Benzinga Life Science Investor Forum: Presentations Now Available for Online Viewing June 23, 2023 From Virtual Investor Conferences Via GlobeNewswire Life Science Investor Forum Agenda Announced for June 22nd June 20, 2023 From Virtual Investor Conferences Via GlobeNewswire MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University June 20, 2023 Via Benzinga Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M June 13, 2023 Via Benzinga Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia June 12, 2023 Via Benzinga USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States June 09, 2023 From PharmAla Biotech Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
